Enoxaparin Sodium Injection

About Gland Pharma

Gland Pharma's mission is to be a leading global provider of high-quality, affordable injectable medicines. The company has achieved this through a combination of deep expertise in complex sterile manufacturing, strategic partnerships like the one with Fosun Pharma, and a successful IPO in 2020. Its core strategy focuses on expanding its CDMO business, leveraging its R&D for differentiated formulations, and penetrating new regulated and emerging markets to drive sustainable growth.

About Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

Hebei Changshan Biochemical Pharmaceutical's mission is to be a global leader in the development and supply of high-quality, life-saving anticoagulant therapies. Its core achievement is establishing itself as a vertically integrated powerhouse in the heparin value chain, from sourcing to finished dosage forms, serving consistent global demand. The company's strategy focuses on leveraging its proprietary biochemical processing platform to maintain cost and quality leadership, while expanding its portfolio of low molecular weight heparin (LMWH) products and exploring novel antithrombotic candidates. Its significant market valuation reflects its entrenched position in this essential therapeutic area.

About Amphastar Pharmaceuticals

Amphastar Pharmaceuticals' mission is to develop, manufacture, and market essential, high-barrier-to-entry pharmaceuticals, with a strategic focus on complex generics, proprietary products, and biosimilars. The company has achieved significant recognition, including an FDA Drug Shortage Assistance Award for its subsidiary, and commercial success with market-leading products like BAQSIMI® nasal glucagon. Its strategy leverages a fully integrated operational model, combining proprietary technology platforms in drug delivery with a diversified portfolio targeting endocrinology, pulmonology, and nephrology to drive sustainable growth.

Therapeutic Areas

Other Anticoagulation Drugs